Back to companies
Corvus Pharmaceuticals, Inc.
CRVSUSNASDAQPharmaceuticals & HealthcareCorvus Pharmaceuticals, Inc.
Revenue
—
FY2025
Operating income
-$43.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API